Is NCT07151248 recruiting in Atlanta, GA?

Yes, NCT07151248 is currently recruiting participants at its Atlanta, GA location. This gulf war syndrome clinical trial is actively enrolling qualified participants.

How do I join the gulf war syndrome clinical trial in Atlanta?

To join this clinical trial in Atlanta, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Atlanta clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Gulf War Syndrome Clinical Trial in Atlanta, GA

About This Gulf War Syndrome Study in Atlanta

The main goal of the proposed study is to critically evaluate a nonpharmacological and readily available therapy, cranial electrical stimulation (CES) using Alpha-Stim™, and to discover the brain function mechanisms underlying Gulf War Illness-related Headache and Pain (GWI-HAP) and treatment response to CES. For this objective, the investigators will employ an adaptive trial design as well as a neuroimaging technique using MRI, which has become the pre-eminent technique for assessing the integrity of brain function, connectivity, and organization in healthy brain and pathology.

Sponsor: Emory University

Who Can Participate

Inclusion Criteria

Subjects must be male and female age 40-80 years old

Meet criteria for GWVI based on the CDC and Kansas Criteria for GWVI.

CDC: 1 or more from at least 2 of the following categories for ≥ 6 months): 1) fatigue 2) mood and cognition (symptoms of feeling depressed, difficulty in remembering or concentrating, feeling moody, feeling anxious, trouble in finding words, or difficulty in sleeping) 3) musculoskeletal (symptoms of joint pain, joint stiffness, or muscle pain

Kansas: 3 of 6 domains: 1) fatigue and sleep problems 2) pain symptoms 3) neurologic, cognitive, or mood symptoms 4) gastrointestinal symptoms 5) respiratory symptoms 6) skin symptoms chronic since 1990. Symptom reporting must be in the absence of diagnosed

Exclusion Criteria

ary conditions; only respondents who have at least 1 moderately severe symptom or 2 or more symptoms within a group were considered to have a high level of symptoms in the group.

Subjects must self-report consistent, daily pain (greater than or equal to 4 on the DVPRS) \>90 days (prior to enrollment)

Subjects must have intact skin free of infection at the site of electrode placement (earlobe).

Subjects must be willing to participate and understand the consent.

Subjects must be right-handed to provide consistency in brain structure and function. Exclusion Criteria:

Subjects must not be currently pregnant since effects of fMRI and electrical current on the developing fetus are not well-known.

Subjects must not have a history of drug abuse or severe, uncontrolled psychiatric illness such as schizophrenia or major depressive disorder with suicidal ideation.

Subjects must not have psoriasis vulgaris or other skin conditions that may increase the risk of infection at the implantation site.

Subjects must not introduce new medications or treatments for symptoms during the study to prevent confounding results.

Subjects must not have severe anxiety, claustrophobia, or other conditions that may prevent their ability to lie at rest in an MRI scanner. This will be determined after discussion with the patient regarding their own perceived ability to lie at rest in an MRI scanner without the use of additional sedating medications.

Subjects must not have an implanted electrical device such as a surgically placed vagal stimulator, pacemaker, or spinal pain pump, which are not compatible with MRI.

Subjects must not have a history of seizures or neurologic conditions that may alter the structure of the brain.

Subjects must not be allergic to the metals used in electrodes for CES stimulation.

Subjects must not have a diagnosed autoimmune disease that better explains pain symptoms.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Atlanta?

Yes, this clinical trial (NCT07151248) has an active research site in Atlanta, GA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Gulf War Syndrome Treatment Options in Atlanta, GA

If you're searching for gulf war syndrome treatment options in Atlanta, GA, this clinical trial (NCT07151248) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gulf war syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all gulf war syndrome clinical trials near you to find additional studies recruiting in your area.

Gulf War Syndrome Clinical Trial in Atlanta, GA

Expert Care in Atlanta

IRB Approved

No-Cost Care

Apply for This Atlanta Location

Why Participate?

Simple Process